Jiawen Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiawen Yao has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Jian Zhou
Sun Yat-sen University Cancer Center
3 shared publicationsLe Lu
DAMO Academy, Alibaba Group
3 shared publicationsLing Zhang
DAMO Academy, Alibaba Group
3 shared publicationsYingda Xia
DAMO Academy, Alibaba Group
3 shared publicationsBin Dong
Peking University
2 shared publicationsHexin Dong
DAMO Academy, Alibaba Group
2 shared publications
Latest Publications
- 1 October 2023
- Published by Springer Nature
- p. 241-251
Improved Prognostic Prediction of Pancreatic Cancer Using Multi-phase CT by Integrating Neural Distance and Texture-Aware Transformer
- 1 October 2023
- Published by Springer Nature
- p. 241-251
Improved Prognostic Prediction of Pancreatic Cancer Using Multi-phase CT by Integrating Neural Distance and Texture-Aware Transformer
- Open Access
Improved Prognostic Prediction of Pancreatic Cancer Using Multi-Phase CT by Integrating Neural Distance and Texture-Aware Transformer
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer in which the tumor-vascular involvement greatly affects the resectability and, thus, overall survival of patients. However, current prognostic prediction methods fail to explicitly and accurately investigate relationships between the tumor and nearby important vessels. This paper proposes a novel learnable neural distance that describes the precise relationship between the tumor and vessels in CT images of different patients, adopting it as a major feature for prognosis prediction. Besides, different from existing models that used CNNs or LSTMs to exploit tumor enhancement patterns on dynamic contrast-enhanced CT imaging, we improved the extraction of dynamic tumor-related texture features in multi-phase contrast-enhanced CT by fusing local and global features using CNN and transformer modules, further enhancing the features extracted across multi-phase CT images. We extensively evaluated and compared the proposed method with existing methods in the multi-center (n=4) dataset with 1,070 patients with PDAC, and statistical analysis confirmed its clinical effectiveness in the external test set consisting of three centers. The developed risk marker was the strongest predictor of overall survival among preoperative factors and it has the potential to be combined with established clinical factors to select patients at higher risk who might benefit from neoadjuvant therapy.
Open AccessImproved Prognostic Prediction of Pancreatic Cancer Using Multi-Phase CT by Integrating Neural Distance and Texture-Aware Transformer
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer in which the tumor-vascular involvement greatly affects the resectability and, thus, overall survival of patients. However, current prognostic prediction methods fail to explicitly and accurately investigate relationships between the tumor and nearby important vessels. This paper proposes a novel learnable neural distance that describes the precise relationship between the tumor and vessels in CT images of different patients, adopting it as a major feature for prognosis prediction. Besides, different from existing models that used CNNs or LSTMs to exploit tumor enhancement patterns on dynamic contrast-enhanced CT imaging, we improved the extraction of dynamic tumor-related texture features in multi-phase contrast-enhanced CT by fusing local and global features using CNN and transformer modules, further enhancing the features extracted across multi-phase CT images. We extensively evaluated and compared the proposed method with existing methods in the multi-center (n=4) dataset with 1,070 patients with PDAC, and statistical analysis confirmed its clinical effectiveness in the external test set consisting of three centers. The developed risk marker was the strongest predictor of overall survival among preoperative factors and it has the potential to be combined with established clinical factors to select patients at higher risk who might benefit from neoadjuvant therapy.
- 16 September 2022
- Published by Springer Nature
- p. 344-354
Effective Opportunistic Esophageal Cancer Screening Using Noncontrast CT Imaging
- 16 September 2022
- Published by Springer Nature
- p. 344-354
Effective Opportunistic Esophageal Cancer Screening Using Noncontrast CT Imaging